Stem Legal client Hissey Kientz LLP launched a new practice page this morning related to the FDA recall of ReliOn insulin syringes by Covidien Ltd.
As highlighted by the new practice page:
A total of 4,710 boxes, or 471,000 individual syringes were distributed before the ReliOn recall notice was issued. The FDA says that these syringes were sold at Wal-Mart and Sam’s Club stores between August 1 and October 8, 2008. Patients who purchased the recalled insulin syringes will be provided with a replacement, according to an announcement posted by Wal-Mart.
For those who may have been injured after using one of the mislabeled syringes, the firm also offers a free case evaluation contact form on the right side of the page, and welcomes contact to explain how their legal rights may be protected.
No Comments yet!